Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.70 |
| ▸ | POLB | P06746 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | TP53 | P04637 | 1/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.59 |
| ▸ | ALPG | P10696 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13836493 | 0.87 | ALDH1A1 (0.61) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL17324145 | 0.87 | ALDH1A1 (0.61) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL4888533 | 0.85 | MAPT (0.75) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL17084253 | 0.85 | MEN1 (0.87) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL11679178 | 0.84 | MEN1 (0.77) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL356986 | 0.84 | MAPT (0.68) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL21415471 | 0.84 | ALDH1A1 (0.58) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL11777113 | 0.84 | MAPT (0.68) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL4219569 | 0.84 | ALDH1A1 (0.58) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL30933151 | 0.84 | MAPT (0.68) | MAPTMEN1KMT2ASMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112886052-A | Composite electrolyte material, preparation method thereof and quasi-solid battery | 昆山宝创新能源科技有限公司 | 2021-06-01 | — | — | CN | claimed |
| CN-113474156-B | Polyamic acid resin composition, polyimide resin film and method for producing same, laminate, and electronic device and method for producing same | 东丽株式会社 | 2022-04-29 | — | — | CN | disclosed |
| CN-113474156-A | Polyamic acid resin composition, polyimide resin film and method for producing same, laminate, and electronic device and method for producing same | 东丽株式会社 | 2021-10-01 | — | — | CN | disclosed |
| CN-112886052-A | Composite electrolyte material, preparation method thereof and quasi-solid battery | 昆山宝创新能源科技有限公司 | 2021-06-01 | — | — | CN | disclosed |
| US-9856254-B2 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-01-02 | — | — | US | disclosed |
| US-9611273-B2 | Trioxane thioacetal monomers and dimers and methods of use thereof | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-04-04 | — | — | US | disclosed |
| US-20160280707-A1 | ALKOXY SUBSTITUTED IMIDAZOQUINOLINES | 3M INNOVATIVE PROPERTIES CO (US) | 2016-09-29 | — | — | US | disclosed |
| US-20160280707-A1 | ALKOXY SUBSTITUTED IMIDAZOQUINOLINES | 3M INNOVATIVE PROPERTIES CO (US) | 2016-09-29 | — | — | US | disclosed |
| US-9365567-B2 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-06-14 | — | — | US | disclosed |
| US-9365567-B2 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-06-14 | — | — | US | disclosed |
| US-4677202-A | Quaternized 2,1,4-benzoxatellurazinium and 2,1,4-naphthoxatellurazinium salt derivitives | EASTMAN KODAK COMPANY (US) | 1987-06-30 | — | — | US | disclosed |
| US-4661438-A | Quaternized tellurium salt fog inhibiting agents for silver halide photography | EASTMAN KODAK COMPANY (US) | 1987-04-28 | — | — | US | disclosed |
| EP-0201201-A2 | Amido substituted divalent chalcogenide fog inhibiting agents for silver halide photography | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-11-12 | — | — | EP | disclosed |
| EP-0198634-A2 | Quaternized tellurium salt fog inhibiting agents for silver halide photography | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-10-22 | — | — | EP | disclosed |
| EP-0192464-A2 | Tellurium salt fog inhibiting agents for silver halide photography | EASTMAN KODAK COMPANY (US) | 1986-08-27 | — | — | EP | disclosed |
| EP-0192466-A2 | Novel chalcogen heterocycles, processes for their preparation, and articles containing such heterocycles | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-08-27 | — | — | EP | disclosed |
| US-4581330-A | AROMATIC OXATELLURAZINIUM SALTS | EASTMAN KODAK COMPANY (US) | 1986-04-08 | — | — | US | disclosed |
| US-4576905-A | Photographically useful chalcogenazoles, chalcogenazolines, and chalcogenazolinium and chalcogenazolium salts | EASTMAN KODAK COMPANY (US) | 1986-03-18 | — | — | US | disclosed |
| EP-0138362-A2 | Photographic materials containing chalcogenazoles, chalcogenazolines and chalcogenazolinium and chalcogenazolium salts | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-04-24 | — | — | EP | disclosed |
| EP-0136847-A2 | Photographically useful chalcogenazolylidene and chalcogenazolium dyes and methods for their preparation | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160280707-A1 | ALKOXY SUBSTITUTED IMIDAZOQUINOLINES | IL2, IFNG, IRF3 | MAPT 4571/4885MEN1 3720/4885KMT2A 2789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.